Amyloidosis Africa is a pan-African initiative that brings together cardiologists from across the continent to address the growing but hidden burden of cardiac amyloidosis. Launched by CRK Clinical Research Key and the Kenya Cardiac Society (KCS), we aim to raise awareness, educate health professionals, and drive continent-wide research collaboration for early diagnosis and improved patient care.
Amyloidosis Africa began as a clinical collaboration between cardiologists in Kenya, driven by the growing concern of underdiagnosed cardiac amyloidosis in African populations.
With support from national societies and research networks, we expanded across Africa, uniting doctors, researchers, and policymakers under one mission: equity in rare disease care.
We now serve as a central platform for awareness campaigns, training programs, policy advocacy, and research, shining a light on a once-forgotten disease.
We're working daily with clinicians and institutions across Africa to elevate the diagnosis and treatment of cardiac amyloidosis.
Amyloidosis Africa is dedicated to:
Raising awareness of ATTR amyloidosis across Africa
Promoting early and accurate diagnosis
Educating healthcare professionals through evidence-based programs
Supporting research, registries, and quality improvement initiatives
Advocating for equitable access to diagnostics and care

Improve recognition of red-flag features and align practice with international standards from the European Society of Cardiology and American Heart Association .

Seek evaluation for persistent or unexplained symptoms and learn from trusted organizations such as the Amyloidosis Foundation .

Collaborate to develop referral pathways, registries, and diagnostic capacity across African health systems.

Support African-led data generation to ensure representation in global amyloidosis research.
Voices From
Amyloidosis Africa
We are building a continent-wide network of cardiologists committed to improving care for patients with amyloidosis. This collaboration is long overdue and necessary.

Cardiac amyloidosis is no longer a rare disease, it’s a rarely diagnosed one. Through Amyloidosis Africa, we are reshaping how Africa detects and manages this hidden epidemic.
Mauris et tortor sit amet ex sagittis feugiat praesent rutrum, lorem ipsum dolor sit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec eget dolor ante.
Mauris et tortor sit amet ex sagittis feugiat praesent rutrum, lorem ipsum dolor sit.
Mauris et tortor sit amet ex sagittis feugiat praesent rutrum, lorem ipsum dolor sit.
Suspendisse quis ipsum vitae leo tincidunt eleifend. Nullam eget condimentum velit.
Phasellus luctus nec turpis ultricies hend rerit. Nullam ut tellus lacus donec faucibus.
Suspendisse quis ipsum vitae leo tincidunt eleifend. Nullam eget condimentum velit.
We work across Africa to improve awareness, early diagnosis, research, and access to care for people affected by amyloidosis.
We advance cardiac amyloidosis care across Africa through collaboration, training, and research. Join us to change the future of heart health and empower local clinicians with knowledge and tools.